Yuichiro Okumura, Takehiro Noda, Hidetoshi Eguchi, Takuya Sakamoto, Yoshifumi Iwagami, Daisaku Yamada, Tadafumi Asaoka, Hiroshi Wada, Koichi Kawamoto, Kunihito Gotoh, et al. Hypoxia-Induced PLOD2 is a Key Regulator in Epithelial-Mesenchymal Transition and Chemoresistance in Biliary Tract Cancer. Annals of surgical oncology. 2018. 25. 12. 3728-3737
Satoshi Matsukuma, Kazuhiko Sakamoto, Yoshihiro Tokuhisa, Yukio Tokumitsu, Hiroto Matsui, Shinsuke Kanekiyo, Shinobu Tomochika, Michihisa Iida, Nobuaki Suzuki, Shigeru Takeda, et al. Outcomes following liver resection for multinodular Barcelona Clinic Liver Cancer-B hepatocellular carcinoma. Oncology letters. 2018. 16. 5. 6383-6392
Hiroya Iida, Masaki Kaibori, Hiroshi Wada, Fumitoshi Hirokawa, Takuya Nakai, Masahiko Kinoshita, Michihiro Hayashi, Hidetoshi Eguchi, Shoji Kubo. Prognostic factors of hepatectomy in initially unresectable colorectal liver metastasis: Indication for conversion therapy. Molecular and clinical oncology. 2018. 9. 5. 545-552
Takahashi H, Akita H, Ioka T, Wada H, Tomokoni A, Asukai K, Ohue M, Yano M, Ishikawa O. Phase I Trial Evaluating the Safety of Preoperative Gemcitabine/nab-Paclitaxel With Concurrent Radiation Therapy for Borderline Resectable Pancreatic Cancer. Pancreas. 2018. 47. 9. 1135-1141
Katayama K, Imai T, Abe Y, Nawa T, Maeda N, Nakanishi K, Wada H, Fukui K, Ito Y, Yokota I, et al. Number of Nodules but not Size of Hepatocellular Carcinoma Can Predict Refractoriness to Transarterial Chemoembolization and Poor Prognosis. Journal of clinical medicine research. 2018. 10. 10. 765-771
